A COMPARATIVE STUDY OF ETOMIDATE AND THIOPENTONE IN MODIFIED E.C.T by Gupta, U.K. et al.
Indian Journal of Psychiatry, April 1986, 28 (2), pp. 151-154 
A COMPARATIVE STUDY OF ETOMIDATE AND 
THIOPENTONE IN MODIFIED E.C.T 
U.K. GUPTA, M.D
1 
R.K. MAHENDRU, M.D
2 
R.K. MEHTA, M.D
3 
POONAM SONKAR
4 
SUMMARY 
The study was undertaken to assess the value of ctomidate in modifed E.C.T. and compare the results 
with thiopentone sodium. Fifty patients of schizophrenia, depressive illness and manic depressive psychosis requir-
ing E.C.T. were studied with thiopentone and ctomidate in two suhsequciit sittings. The results indicate that in-
duction time is approximately same with both the drugs. The shorter recovery time with ctomidate in comparison 
to thiopentone proved to be ot definite advantage specially to psychiatric out patients who rapidly have to regain 
consciousness and soon become alert enough to go back to their homes alter treatment. 
Thiopentone sodium is still the most 
commonly used anaesthetic agent'for mo-
dified E. C.T. (Sargant and Slater 1963, Ka-
linowsky 1975) but the hang-over associat-
ed with its use is a definite disadvantage 
specially in psychiatric outpatient depart-
ments where patients have to go back to 
their homes soon after the treatment. Many 
new intravenous anaesthetic agents are be-
ing evaluated in modified E.C.T. in order 
to find a drug which is more safe, effective 
and has a rapid recovery period. 
Etomidate is a potent, rapidly acting, 
non-barbiturate intravenous anaesthetic 
agent introduced into clinical practice by 
Doenicke et al (1973). The present study 
was undertaken to compare thiopentone 
sodium and etomidate as intravenous anaes-
thetic agents for modified electroconvul-
sive therapy. 
Material and Methods 
The investigation was carried out on 50 
randomly selected patients attending men-
tal health clinic of L.L.R. Hospital, Kan-
pur. Patients of both sexes between the age 
group of 16 to 60 years who had to undergo 
E. C.T. were taken up for the study. Every 
patient was studied in the first two sittings 
of E.C.T. The relative drug responses of 
the two inducing agents were evaluated in 
their standard doses. In the first sitting, 
thiopentone sodium was used as induction 
agent in doses of 5 mg/kg body weight. In 
the second sitting etomidate was given in 
doses of 0.3 mg/kg of body weight. The pa-
tients were given nothing orally after 10 
PM in the preceding night. 
No premedication was given. Atropine 
in the dose of 1 mg I. V. was given with in-
duction agent (Thiopentone Sodium). The 
induction time (in seconds) i.e. the time in-
terval from start of injection to loss of eye 
reflexes was noted. Suxamethonium in the 
dose 0.7 mg/kg body weight was given and 
oxygenation by I. P. P. R. was done during 
apnoea. E.C.T. was given after proper rela-
xation. Intensity of convulsions wcr^aoted 
according to following grades: -
Grade I - Twitching of facial muscles 
and toes 
Grade II - Soft generalised convulsions 
Grade III - Unmodified convulsions 
Total apnoeic period (in seconds) i.e. the 
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time period from start of injection of suxa-
methonium to first post E. C.T. breath was 
noted. Patients were again gently ventilated 
with 100% oxygen using Boyles apparatus 
until adequate spontaneous respiration was 
restored. Recovery time (in minutes) i.e. 
the time interval between the loss of e*ye 
reflexes to return of response to verbal 
commands was noted. 
The procedure was repeated in second 
sitting of E.C.T. in the same patient using 
Etomidate as induction agent at an interval 
of 2 days. 
Reraltf 
Tabic 4 
Intensity of convulsions after E.C.T. in the 
two groups of drugs 
Intensity of Thiopentone sodium Etomidate 
convulsions No. % No. % 
Grade I 
Grade II 
Grade III 
42 
8 
84 
16 
40 
10 
80 
20 
Table 5 
Mean total apnoeic period with the two drugs 
Drugs 
Total apnoric 
period (inse 
conds) 
Significance 
Thiopentone 1602 i 9.4 
•odium 
Etomidate 166.4± 12 
14.198  Not 
significant 
Age group 
(years) 
16-25 
16-35 
36-45 
46-55 
56 & above 
Total 
Tabl 
Age and sex 
Male 
4 
3 
9 
3 
3 
22 
' 
Sex 
e 1 
distribution 
Female 
12 
6 
2 
4 
4 
28 
Total 
16 
9 
11 . 
7 
7 
50 
-
Table 6 
Mean recovery time with the 
__ Recovery rime „ 
Dru8» (in seconds)
 V 
Thiopentone 8.6 i 1.9 
sodium 
14.198 
(rx-ooi) 
Etomidate 42 ± 1.1 
Discussion 
two drugs 
Significance 
(p<.00l) 
stgnincant 
Table 2 
Diagnostic distribution of patients 
Diagnosis  Number Percentage 
Schizophrenia 30 60 
Involutional depression 15 30 
Manic depressive psychosis 5 10 
Table 3 
Mean induction time with the two drugs 
Drug  Induction - time 
(in seconds) 
level of 
signifi 
cance 
Thiopcnt- 32.3 ± 2.5 
one sodium 
Etomidate 33.6 ± 1.8 
2.984  Not 
significant 
Though thiopentone is the most popu-
lar inducing agent for modified E. C. T its 
use is not without risk specially in patients 
with cardiac and respiratory problems. The 
supremacy of the intravenous barbiturates 
for the rapid induction of anaesthesia has 
been challenged in recent years by a group 
of new drugs. Etomidate is one of them and 
it was thought worthwhile to try this drug 
as inducing agent for modified E.C.T. 
The induction time with thiopentone 
found in our study was 323 ± 2.5 seconds. 
Different workers (Dundee 1957), Wyant 
and Barr (1960) and Fox et al (1968) have 
found different induction times with thio-
pentone varying from 15 to 150 seconds. 
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Table 7 
Side effects with the two drugs 
Side effects 
Thiopentone sodium 
No. of 
case's 
Percentage 
Etomidate 
No. of  Percentage 
I- During Induction 
Involuntary muscle 
movements 
Flushing 
Laryngospasm 
Pain duritig injection 
Hiccough 
II - Early 
Prolonged apnoea 
Cvnosis 
Arrhythnuas 
Nausea, vomiting 
Secietions 
Marked confusion 
III - Late 
Drowsiness 
Headache 
Thrombophlebitis 
6.0 
4.0 
-
-
18 
-
20 
1 
36.0 
-
40.0 
2.0 
4 
6 
2 
-
13 
10 
1 
8.0 
12.0 
4.0 
-
26.0 
20.0 
2.0 
\  -
3 
2 
1 
2 
5 
-
6.0 
4.0 
2.0 
4.0 
10.0 
could be due to dose of the drug, the speed 
of injection and the senstivity of the pat-
ient. The present study has revealed more 
or less similar induction time (33.6 ± 18 
sec.) with etomidate as well.-The studies of 
Morgan et al (1975) and Faniewo et al 
(1977) have shown nearly similar findings. 
They have found induction time of etomid-
ate to be in the range of 10 to 65 seconds de-
pending on the dose, rate of injection and 
the type ot premedication. The intensity of 
convulsions was more or less same with the 
two types of drugs. Nearly 80% patients in 
both the groups exhibited grade I convul-
sions. 
The simple test of the response to verbal 
commands was taken as criteria for recov-
ery. The recovery time with thiopentone 
was much longer 8.6 ±1.9 minutes as com-
pared to 4.2 ±1.1 minutes with etomidate. 
This difference in recovery time between 
the two drugs was found to be statistically 
significant. Similar results with regard to 
recovery time of etomidate have also been 
reported by O' Carroll (1977). The drow-
siness associated with thiopentone is a defi-
nite disadvantage particularly in busy 
psychiatric clinics where • the large 
number of patients are given E.C.Ts who 
are sent back to their homes after treat-
ment. 
The early recovery time seen with eto-
midate is a desirable feature specially in 
psychiatric out patient departments where 
the patients have to go home immediately 
after E.C.T. Shortening of the recovery 
time can save lot of valuable time of the 
anaesthetist without compromising safety 
of the patients. 
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apnocic period between thiopentone 
(160.2 ± 9.4 seconds) and etomidate (166.4 
± 7.2). The apnoeic period does not affect 
the suitability of the either of the agent. 
Some pain during injection was com-
plained by 40% of the patients with etomid» 
ate while thiopentone did not cause pain in 
any patient during injection. Involuntary 
muscle movements during induction were 
seen in 6% cases with thiopentone and in 
36% patients with etomidate. The high in-
cidence of pain during injection and invo-
luntary muscle movements are also report-
ed by Fragcn et al (1976), Goodling et al 
' (1976) and O' Carroll et al'(1977). The pain 
and involuntary muscle movements were 
short lived and the patients had no prob-
lems in this respect after the treatment was 
over. The incidence of arrhythmias with 
thiopentone was 8% while no cardiac irre-
gularities were observed with the use of 
etomidate. The observed cardiovascular 
stability with the use of etomidate is an ad-
ditional quality which can make it more 
useful in psychiatric patients with cardio-
vascular disorders requiring electro-con-
vulsive therapy. The frequency of nausea 
and vomiting with thiopentone was higher 
(12%) as compared to etomidate (6%). The 
occurrence of excessive secretions was 
more or less equal. 26% patients with thio-
pentone showed post E. C.T drowsiness, 
while no patient with etomidate had drow-
siness. 
Conclusion 
Thiopentone shows smooth rapid in-
duction. Patients have definite barbiturate 
hangover and tendency to sleep after 
electro convulsive therapy. Etomidate in-
duction is associated with involuntary 
muscle movements and some pain during 
injection. Early and uneventful recovery 
shows its distinct advantage over thiopen-
tone sodium. Etomidate definitely has a 
place as intravenous anaesthetic agent for 
E. C. T and more clinical trials are called for 
its further evaluation. 
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